These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2622018)

  • 41. [Disorders in the contact phase system of blood coagulation as a cause of increased partial thromboplastin time].
    Siegert G; Plat M
    Z Gesamte Inn Med; 1988 May; 43(9):228-31. PubMed ID: 3407236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory management of the bleeding patient.
    Taylor LJ
    Clin Lab Sci; 2003; 16(2):111-4. PubMed ID: 12757191
    [No Abstract]   [Full Text] [Related]  

  • 43. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
    Horiuchi N; Aoki Y; Terada H
    Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
    [No Abstract]   [Full Text] [Related]  

  • 45. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction.
    Lodi S; Isa L; Pollini E; Bravo AF; Scalvini A
    Scand J Haematol; 1984 Jul; 33(1):80-2. PubMed ID: 6463588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Factor VII].
    Nagaizumi K; Fukutake K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():636-9. PubMed ID: 15658410
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical significance of factor XI analysis in blood coagulation tests].
    Saito H
    Nihon Rinsho; 1989 Dec; 48 Suppl():840-2. PubMed ID: 2622015
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical significance of platelet factor 4 analysis in blood coagulo-fibrinolytic tests].
    Kimura A; Kuramoto A
    Nihon Rinsho; 1989 Dec; 48 Suppl():927-9. PubMed ID: 2622031
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical significance of bleeding time in blood coagulo-fibrinolytic tests].
    Samori T
    Nihon Rinsho; 1989 Dec; 48 Suppl():934-7. PubMed ID: 2622032
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on Fletcher trait and Fitzgerald trait. A rare chance to disclose body's defense reactions against injury.
    Saito H
    Thromb Haemost; 2010 Nov; 104(5):867-74. PubMed ID: 20838736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 52. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis.
    Downey C; Kazmi R; Toh CH
    Thromb Haemost; 1998 Jul; 80(1):65-9. PubMed ID: 9684787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
    Dempfle CE; Lorenz S; Smolinski M; Wurst M; West S; Houdijk WP; Quintel M; Borggrefe M
    Crit Care Med; 2004 Feb; 32(2):520-4. PubMed ID: 14758173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Factor IX and factor IX inhibitor].
    Higasa S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413
    [No Abstract]   [Full Text] [Related]  

  • 56. Isolated prolonged activated partial thromboplastin time in an asymptomatic patient: Fletcher factor deficiency.
    Acar K; Yağci M; Sucak GT; Haznedar R
    Thromb Res; 2006; 118(6):765-6. PubMed ID: 16414101
    [No Abstract]   [Full Text] [Related]  

  • 57. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 59. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
    Gordon EM; Ratnoff OD; Goldsmith GH
    J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
    Matsuno K; Araki K
    Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.